SCHEMBL14680504

SCHEMBL14680504

Cc1ccc2cc3ccc(O)cc3c(O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 1/20 0.43
▸ CYP1A2 P05177 4/20 0.42
▸ CYP2A6 P11509 3/20 0.42
▸ ACHE P22303 2/20 0.42
▸ ESR1 P03372 4/20 0.40
▸ ESR2 Q92731 4/20 0.40
▸ PTGES O14684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ MAP2K4 P45985 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.39
▸ MAPKAPK3 Q16644 1/20 0.39
▸ MAPK6 Q16659 1/20 0.39
▸ MAPKAPK5 Q8IW41 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ FLT3 P36888 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29876780 0.87 ESR1 (0.47) MCL1CYP1A2ESR1ESR2KDM4E
SCHEMBL125041 0.87 ESR1 (0.47) MCL1CYP1A2ESR1ESR2KDM4E
SCHEMBL21920117 0.83 CYP1A2 (0.48) CYP1A2CYP2A6KDM4EALDH1A1LMNA
Methane SCHEMBL7936815 0.80 CYP2A6 (0.48) CYP1A2CYP2A6ALDH1A1GAAHPGD
SCHEMBL15869807 0.78 CYP1A2 (0.52) CYP1A2CYP2A6ACHEESR1ESR2
SCHEMBL19202200 0.77 TRPA1 (0.44) CYP1A2CYP2A6KDM4EALDH1A1LMNA
SCHEMBL14742461 0.77 CYP1A2 (0.54) MCL1CYP1A2ESR1ESR2KDM4E
SCHEMBL12017090 0.76 CYP2A6 (0.62) CYP1A2CYP2A6ACHEESR1ESR2
SCHEMBL8340063 0.75 TRPA1 (0.43) CYP1A2CYP2A6ACHEESR1ESR2
SCHEMBL13021181 0.75 CYP1A2 (0.45) CYP1A2CYP2A6ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8778876-B2 Small-molecule inhibitors of Dengue and West Nile virus proteases THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-07-15 — — US disclosed
US-8778876-B2 Small-molecule inhibitors of Dengue and West Nile virus proteases THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-07-15 — — US disclosed
US-20130035284-A1 SMALL-MOLECULE INHIBITORS OF DENGUE AND WEST NILE VIRUS PROTEASES THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-02-07 — — US disclosed
US-20130035284-A1 SMALL-MOLECULE INHIBITORS OF DENGUE AND WEST NILE VIRUS PROTEASES THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-02-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035284-A1 SMALL-MOLECULE INHIBITORS OF DENGUE AND WEST NILE VIRUS PROTEASES SPINT2, ADAM17, ADAM33 MCL1 4294/4885CYP1A2 3045/4885CYP2A6 2605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback